If your lab is already committed to molecular diagnostic testing, this new
report gives you the detailed data and analysis and expert insight that will
guide you in your strategic planning in the coming years.
And if you’re still considering molecular diagnostic testing, you can
learn more about it from the contributions of scores of molecular diagnostics
experts and dozens of lab executives, as well as from the data and analysis
of the survey responses of over 300 lab professionals.
Briefly, the report covers:
- The molecular diagnostics market
- Integrating molecular diagnostics into your lab
- Point-of-care testing
- Regulations, pricing and reimbursement
- Pharmacogenomics
- Washington G-2 Reports’ molecular diagnostics survey
o Demographics
o Making the molecular diagnostic decision
o Molecular diagnostics budget and costs
o Building the test menu
For more detail, click below to review the entire Table of Contents.
In addition, the report includes extensive appendices, including the top 100
molecular diagnostic labs; labs offering molecular diagnostic tests by test
volumes; profiles of leading labs; FDA-approved molecular diagnostic tests;
and, a directory of tests by company.
Preview this report's Table of Contents and Preface.
